Information  X 
Enter a valid email address

Oxford Biodyn Ord GBP0.01 (OBD)

Related News

28-Jun-2022 11:09 AM

Oxford BioDynamics shares drop as it might need funding by early 2023

Oxford BioDynamics PLC on Tuesday said it will need additional funding - either internal or external - by early 2023, as it posted a sharp drop in half-year revenue, sending its shares tumbling. The Oxford, England-based biotechnology firm is f
21-Jun-2022 10:47 AM

Oxford Biodynamics shares jump as CiRT blood test available in UK

Oxford BioDynamics PLC shares rose on Tuesday on news that the biotechnology firm's checkpoint inhibitor response test is now available in the UK. The stock was trading 8.0% higher at 17.55 pence each in London on Tuesday morning.
09-Apr-2021 08:11 AM

Oxford BioDynamics signs lease for new lab and office space at Oxford Business Park

Biotechnology company Oxford BioDynamics has signed a lease agreement for new laboratory and office space at Oxford Business Park as part of plans to significantly expand its UK facilities. The 24,000 sq ft premises will house the company's growing
16-Jun-2020 07:49 AM

Oxford BioDynamics posts loss as revenue falls, costs rise

Biomarker company Oxford BioDynamics posted a first-half loss after revenue fell and costs rose. Pre-tax losses for the six months through March amounted to £2.3m, compared to losses of £1.6m on-year. Revenue slipped to £0.2m, back fro
28-May-2019 08:30 AM

Oxford BioDynamics posts first-half loss as expenses offset rising sales

Biomarker developer Oxford BioDynamics booked a first-half loss after rising revenue was more than offset by expenses, including staff and R&D costs. Pre-tax losses for the six months through March amounted to £1.6m, compared to losses of £1.
11-Dec-2018 07:34 AM

Oxford BioDynamics books annual loss amid flat sales, rising costs

Bio-marker company Oxford BioDynamics booked an annual loss as it increased spending on R&D and staff while revenue remained flat. Pre-tax losses for the year through September amounted to £2.4m, compared to losses of £4.0m on-year, when the
19-Jul-2018 07:41 AM

Oxford BioDynamics granted Canadian patent for EpiSwitch, its proprietary technology platform

Biotech company Oxford BioDynamics announced that the Canadian Intellectual Property Office has granted it a patent for EpiSwitch, its novel technology platform. "This patent strengthens our global intellectual property position and further validate
22-May-2018 09:58 AM

Oxford BioDynamics losses narrow as administrative costs fall

Bio-marker developer Oxford BioDynamics said first-half losses narrowed after revenue ticked up and it incurred IPO costs in the previous year. Pre-tax losses amounted to £1.4m, compared to a loss in the previous corresponding period of £2.7m
30-Jan-2018 09:59 AM

Oxford BioDynamics losses widen

Oxford BioDynamics said its annual losses doubled following an increase in staff costs and expenses relating to its share market float. The company booked a pre-tax loss of £4.03m, compared to a £2.07m loss a year earlier, despite revenue ris

a d v e r t i s e m e n t